Cited by 14Enzyme Structure and FunctionProtein Tyrosine PhosphatasesProtein Structure and Dynamics

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

An expanded trove of fragment-bound structures for the allosteric enzyme PTP1B from computational reanalysis of large-scale crystallographic data

Open access

Published version of a preprint

Abstract

Due to their low binding affinities, detecting small-molecule fragments bound to protein structures from crystallographic datasets has been a challenge. Here, we report a trove of 65 new fragment hits for PTP1B, an "undruggable" therapeutic target enzyme for diabetes and cancer. These structures were obtained from computational analysis of data from a large crystallographic screen, demonstrating the power of this approach to elucidate many (∼50% more) "hidden" ligand-bound states of proteins. Our new structures include a fragment hit found in a novel binding site in PTP1B with a unique location relative to the active site, one that links adjacent allosteric sites, and, perhaps most strikingly, a fragment that induces long-range allosteric protein conformational responses. Altogether, our research highlights the utility of computational analysis of crystallographic data, makes publicly available dozens of new ligand-bound structures of a high-value drug target, and identifies novel aspects of ligandability and allostery in PTP1B.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.str.2024.05.010

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 50

  1. Krojer, 2020, Discovery of allosteric binding sites by crystallographic fragment screening, Curr. Opin. Struct. Biol., 65, 209, 10.1016/j.sbi.2020.08.004 · DOI
  2. Keedy, 2018, An expanded allosteric network in PTP1B by multitemperature crystallography, fragment screening, and covalent tethering, Elife, 7, 10.7554/eLife.36307 · DOI
  3. Skaist Mehlman, 2023, Room-temperature crystallography reveals altered binding of small-molecule fragments to PTP1B, Elife, 12, 10.7554/eLife.84632 · DOI · Paper page
  4. Douangamath, 2020, Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease, Nat. Commun., 11, 5047, 10.1038/s41467-020-18709-w · DOI
  5. Günther, 2021, X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease, Science, 372, 642, 10.1126/science.abf7945 · DOI
  6. Schuller, 2021, Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking, Sci. Adv., 7, 10.1126/sciadv.abf8711 · DOI
  7. Boby, 2023, Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors, Science, 382, 10.1126/science.abo7201 · DOI
  8. Tonks, 2003, PTP1B: from the sidelines to the front lines!, FEBS Lett., 546, 140, 10.1016/S0014-5793(03)00603-3 · DOI
  9. Zhang, 2007, PTP1B as a drug target: recent developments in PTP1B inhibitor discovery, Drug Discov. Today, 12, 373, 10.1016/j.drudis.2007.03.011 · DOI
  10. Montalibet, 2005, Therapeutic strategies for targeting PTP1B in diabetes, Drug Discov. Today Ther. Strat., 2, 129, 10.1016/j.ddstr.2005.05.002 · DOI
  11. Yip, 2010, PTP1B: a double agent in metabolism and oncogenesis, Trends Biochem. Sci., 35, 442, 10.1016/j.tibs.2010.03.004 · DOI
  12. Lessard, 2010, The two faces of PTP1B in cancer, Biochim. Biophys. Acta, 1804, 613, 10.1016/j.bbapap.2009.09.018 · DOI
  13. Pearce, 2017, A multi-crystal method for extracting obscured crystallographic states from conventionally uninterpretable electron density, Nat. Commun., 8, 10.1038/ncomms15123 · DOI
  14. Ginn, 2020, Pre-clustering data sets using cluster4x improves the signal-to-noise ratio of high-throughput crystallography drug-screening analysis, Acta Crystallogr. D Struct. Biol., 76, 1134, 10.1107/S2059798320012619 · DOI
  15. Srinivasan, 2022, Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease, Commun. Biol., 5, 805, 10.1038/s42003-022-03737-7 · DOI
  16. Godoy, 2023, Allosteric regulation and crystallographic fragment screening of SARS-CoV-2 NSP15 endoribonuclease, Nucleic Acids Res., 51, 5255, 10.1093/nar/gkad314 · DOI
  17. Barthel, 2022, Large-Scale Crystallographic Fragment Screening Expedites Compound Optimization and Identifies Putative Protein-Protein Interaction Sites, J. Med. Chem., 65, 14630, 10.1021/acs.jmedchem.2c01165 · DOI
  18. Fraser, 2011, Accessing protein conformational ensembles using room-temperature X-ray crystallography, Proc. Natl. Acad. Sci. USA, 108, 16247, 10.1073/pnas.1111325108 · DOI
  19. Keedy, 2014, Crystal cryocooling distorts conformational heterogeneity in a model Michaelis complex of DHFR, Structure, 22, 899, 10.1016/j.str.2014.04.016 · DOI
  20. Keedy, 2015, Mapping the conformational landscape of a dynamic enzyme by multitemperature and XFEL crystallography, Elife, 4, 10.7554/eLife.07574 · DOI
  21. Ebrahim, 2022, The temperature-dependent conformational ensemble of SARS-CoV-2 main protease (Mpro), IUCrJ, 9, 682, 10.1107/S2052252522007497 · DOI
  22. Guerrero, 2024, Pushed to extremes: distinct effects of high temperature vs. pressure on the structure of STEP, Commun. Biol., 7, 59, 10.1038/s42003-023-05609-0 · DOI
  23. Berman, 2000, The Protein Data Bank, Nucleic Acids Res., 28, 235, 10.1093/nar/28.1.235 · DOI · Paper page
  24. Greisman, 2023, Discovery and validation of the binding poses of allosteric fragment hits to protein tyrosine phosphatase 1b: From molecular dynamics simulations to X-ray crystallography, J. Chem. Inf. Model., 63, 2644, 10.1021/acs.jcim.3c00236 · DOI
  25. Torgeson, 2022, Conserved conformational dynamics determine enzyme activity, Sci. Adv., 8, 10.1126/sciadv.abo5546 · DOI
  26. Sharma, 2024, High-resolution double vision of the allosteric phosphatase PTP1B, Acta Crystallogr. F Struct. Biol. Commun., 80, 1, 10.1107/S2053230X23010749 · DOI
  27. Whittier, 2013, Conformational motions regulate phosphoryl transfer in related protein tyrosine phosphatases, Science, 341, 899, 10.1126/science.1241735 · DOI
  28. Critton, 2011, Visualizing active-site dynamics in single crystals of HePTP: opening of the WPD loop involves coordinated movement of the E loop, J. Mol. Biol., 405, 619, 10.1016/j.jmb.2010.11.020 · DOI
  29. Tautermann, 2019, Allosteric Activation of Striatal-Enriched Protein Tyrosine Phosphatase (STEP, PTPN5) by a Fragment-like Molecule, J. Med. Chem., 62, 306, 10.1021/acs.jmedchem.8b00857 · DOI
  30. Wiesmann, 2004, Allosteric inhibition of protein tyrosine phosphatase 1B, Nat. Struct. Mol. Biol., 11, 730, 10.1038/nsmb803 · DOI
  31. Sharma, 2023, Room-temperature serial synchrotron crystallography of the human phosphatase PTP1B, Acta Crystallogr. F Struct. Biol. Commun., 79, 23, 10.1107/S2053230X22011645 · DOI
  32. Olmez, 2011, Alpha7 helix plays an important role in the conformational stability of PTP1B, J. Biomol. Struct. Dyn., 28, 675, 10.1080/07391102.2011.10508599 · DOI
  33. Choy, 2017, Conformational Rigidity and Protein Dynamics at Distinct Timescales Regulate PTP1B Activity and Allostery, Mol. Cell, 65, 644, 10.1016/j.molcel.2017.01.014 · DOI
  34. Gahbauer, 2023, Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2, Proc. Natl. Acad. Sci. USA, 120, 10.1073/pnas.2212931120 · DOI
  35. Corso, 2022, DiffDock: Diffusion Steps, Twists, and Turns for Molecular Docking, arXiv
  36. Krishna, 2024, Generalized Biomolecular Modeling and Design with RoseTTAFold All-Atom., Science, 384, 10.1126/science.adl2528 · DOI · Paper page
  37. Dong, 2023, Equivariant Flexible Modeling of the Protein-Ligand Binding Pose with Geometric Deep Learning, J. Chem. Theor. Comput., 19, 8446, 10.1021/acs.jctc.3c00273 · DOI
  38. Weiss, 2022, Of problems and opportunities-How to treat and how to not treat crystallographic fragment screening data, Protein Sci., 31, 10.1002/pro.4391 · DOI · Paper page
  39. Fraser, 2009, Hidden alternative structures of proline isomerase essential for catalysis, Nature, 462, 669, 10.1038/nature08615 · DOI
  40. Fischer, 2015, One Crystal, Two Temperatures: Cryocooling Penalties Alter Ligand Binding to Transient Protein Sites, Chembiochem, 16, 1560, 10.1002/cbic.201500196 · DOI
  41. Bradford, 2021, Temperature artifacts in protein structures bias ligand-binding predictions, Chem. Sci., 12, 11275, 10.1039/D1SC02751D · DOI
  42. Mirdita, 2022, ColabFold: making protein folding accessible to all, Nat. Methods, 19, 679, 10.1038/s41592-022-01488-1 · DOI · Paper page
  43. Baek, 2023, Efficient and accurate prediction of protein structure using RoseTTAFold2, bioRxiv
  44. Emsley, 2010, Features and development of Coot, Acta Crystallogr. D Biol. Crystallogr., 66, 486, 10.1107/S0907444910007493 · DOI · Paper page
  45. Moriarty, 2009, electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation, Acta Crystallogr. D Biol. Crystallogr., 65, 1074, 10.1107/S0907444909029436 · DOI
  46. Pearce, 2017, Proper modelling of ligand binding requires an ensemble of bound and unbound states, Acta Crystallogr. D Struct. Biol., 73, 256, 10.1107/S2059798317003412 · DOI
  47. Liebschner, 2019, Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix, Acta Crystallogr. D Struct. Biol., 75, 861, 10.1107/S2059798319011471 · DOI · Paper page
  48. Murshudov, 2011, REFMAC5 for the refinement of macromolecular crystal structures, Acta Crystallogr. D Biol. Crystallogr., 67, 355, 10.1107/S0907444911001314 · DOI
  49. Landrum, 2013, Rdkit documentation, Release, 1, 4
  50. Schrödinger, 2017, The PyMOL Molecular Graphics System

Metadata

Authors
Mehlman, T., Ginn, H. M., & Keedy, D. A.
Affiliations
  • The Graduate Center, CUNY (US)
  • Universität Hamburg (DE)
Corresponding author
Keedy, Daniel A.
Venue
Structure
Publisher
Elsevier BV
Published
2024-08
Volume
32
Issue
8
Pages
1231-1238.e4
ISSN
0969-2126 (ISSN-L)
OpenAlex
W4399492393
Cited by
14
References
2
Citations by year
2026: 4 · 2025: 10
FWCI
1.37
Type
journal article
Language
en
Open access
Locations
  • Structure (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • PubMed Central (submittedVersion, cc-by)
  • Desy publication database (The Deutsches Elektronen-Synchrotron) (submittedVersion)
  • DESY Publication Database (PUBDB) (Deutsches Elektronen-Synchrotron)
Funders
  • Helmholtz Association of German Research Centres (VH-NG-19-02)
  • National Institutes of Health
  • National Institute of General Medical Sciences (R35 GM133769)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
Keywords
PTP1B, fragment hits, allosteric enzymes, ligand binding sites, ligandability, diabetes mellitus, cancer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review